Magnetic Sentinel Node and Occult Lesion Localisation (MagSNOLL)
Not Applicable
Completed
- Conditions
- Topic: National Cancer Research NetworkSubtopic: Breast CancerDisease: BreastCancerMalignant neoplasm of breast
- Registration Number
- ISRCTN68689512
- Lead Sponsor
- King's College London (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
1. Patients with operable breast cancer visible on ultrasound and suitable for SLNB 2. Neoadjuvant chemotherapy sub-protocol:
Patients with breast cancer due to undergo neoadjuvant chemotherapy and post-chemotherapy SLNB
3. Target Gender: Female ; Lower Age Limit 18 years
Exclusion Criteria
1. Intolerance / hypersensitivity to iron or dextran compounds or Sienna +
2. Patients who cannot / do not receive radioisotope for SLNB
3. Patients with an iron overload disease
4. Patients with pacemakers or other implantable devices in the chestwall
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Successful sentinel lymph node biopsy and lesion localisation.
- Secondary Outcome Measures
Name Time Method o secondary outcome measures